INS and COVID-19: Additionally, a downregulation of the transcription factor REST (RE1-silencing transcription factor) observed in COVID-19 patients is linked to the altered gene expression of glucose and lipid metabolism involving apelin, myostatin myeloperoxidase (peptides and proteins important for the insulin signaling pathway) (He et al., 2021).